ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?
New possibilities of ACE inhibitors application on the base of international trails review are presented. Traditional therapy areas of ACE inhibitors (hypertension, heart failure) are well known. However recent studies have shown that ACE inhibitors improve prognosis in patients with clinically prov...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/859 |
| _version_ | 1826949758339514368 |
|---|---|
| author | D. V. Nebieridze A. S. Safarian |
| author_facet | D. V. Nebieridze A. S. Safarian |
| author_sort | D. V. Nebieridze |
| collection | DOAJ |
| description | New possibilities of ACE inhibitors application on the base of international trails review are presented. Traditional therapy areas of ACE inhibitors (hypertension, heart failure) are well known. However recent studies have shown that ACE inhibitors improve prognosis in patients with clinically proved atherosclerosis. This ACE inhibitor ability is a result of their high vasoprotective effect. It provides new clinical possibilities for their use for slowing a progression of diseases associated with atherosclerosis. However this property can not be extended to all ACE inhibitors. Only ramipril and perindopril have a strong evidence base. |
| first_indexed | 2024-03-08T14:03:54Z |
| format | Article |
| id | doaj.art-46c2d9763cea415984226322372bb25b |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2025-02-17T22:19:51Z |
| publishDate | 2016-01-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-46c2d9763cea415984226322372bb25b2024-12-04T11:48:07ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-016452853110.20996/1819-6446-2010-6-4-528-531858ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?D. V. Nebieridze0A. S. Safarian1State Research Center for Preventive MedicineState Research Center for Preventive MedicineNew possibilities of ACE inhibitors application on the base of international trails review are presented. Traditional therapy areas of ACE inhibitors (hypertension, heart failure) are well known. However recent studies have shown that ACE inhibitors improve prognosis in patients with clinically proved atherosclerosis. This ACE inhibitor ability is a result of their high vasoprotective effect. It provides new clinical possibilities for their use for slowing a progression of diseases associated with atherosclerosis. However this property can not be extended to all ACE inhibitors. Only ramipril and perindopril have a strong evidence base.https://www.rpcardio.online/jour/article/view/859ace inhibitorsvasoprotectioncomplication risk reductionramiprilgeneric drug |
| spellingShingle | D. V. Nebieridze A. S. Safarian ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Рациональная фармакотерапия в кардиологии ace inhibitors vasoprotection complication risk reduction ramipril generic drug |
| title | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? |
| title_full | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? |
| title_fullStr | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? |
| title_full_unstemmed | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? |
| title_short | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? |
| title_sort | ace inhibitor possibilities in clinical practice what we know about them |
| topic | ace inhibitors vasoprotection complication risk reduction ramipril generic drug |
| url | https://www.rpcardio.online/jour/article/view/859 |
| work_keys_str_mv | AT dvnebieridze aceinhibitorpossibilitiesinclinicalpracticewhatweknowaboutthem AT assafarian aceinhibitorpossibilitiesinclinicalpracticewhatweknowaboutthem |